1970
DOI: 10.1097/00000542-197009000-00012
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of d-Tubocurarine on Spontaneous Postganglionic Sympathetic Activity and Histamine Release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
2
0

Year Published

1974
1974
2014
2014

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 0 publications
2
2
0
Order By: Relevance
“…These changes with d-tubocurarine are identical with a previous study reported by our laboratory showing the effect of a muscle paralyzing dose (0.4 mg/kg) and a 2.5 times the muscle paralyzing dose (1 .O mglkg) of d-tubocurarine on heart rate, MAP, SPGSA and histamine(4). 1B) coincident with an approximate threefold increase in blood histamine (Fig.…”
supporting
confidence: 91%
See 2 more Smart Citations
“…These changes with d-tubocurarine are identical with a previous study reported by our laboratory showing the effect of a muscle paralyzing dose (0.4 mg/kg) and a 2.5 times the muscle paralyzing dose (1 .O mglkg) of d-tubocurarine on heart rate, MAP, SPGSA and histamine(4). 1B) coincident with an approximate threefold increase in blood histamine (Fig.…”
supporting
confidence: 91%
“…dose proportional to the higher dose of pancuronium produced an initial slight increase in heart rate followed by a significant decrease (P < 0.05) at 5 min post injection in confirmation of previous studies (Fig. dose of d-tubocurarine, ganglionic blockade to electrical stimulation as well as a marked elevation in blood histamine could be demonstrated (4). Moreover, d-tubocurarine effected a significant (P < 0.001) fall in mean arterial blood pressure Discussion.…”
supporting
confidence: 89%
See 1 more Smart Citation
“…6 Different from the classic nondepolarizing muscle relaxant d-tubocurare, early studies showed that rocuronium only caused minimal cardiovascular side effects at clinically relevant concentrations, such as a decrease in mean arterial pressure, systemic vascular resistance, and an increase in heart rate, 7 which are supposedly caused by its vagolytic effects. 13 In contrast to these actions, clinically relevant concentrations of rocuronium cause negligible histamine release and vagolytic effects 14 ; however, its side effects might originate from an interaction with neuronal nAChRs. 10,11 Structurally similar to the well-characterized muscle nAChRs, neuronal nAChRs mediate fast synaptic transmission in sympathetic, parasympathetic, and enteric autonomic ganglia and regulate the function of the cardiovascular system.…”
Section: Introductionmentioning
confidence: 99%